DK630088A - Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel - Google Patents
Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middelInfo
- Publication number
- DK630088A DK630088A DK630088A DK630088A DK630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A
- Authority
- DK
- Denmark
- Prior art keywords
- azelastinembonate
- procedures
- preparing
- compound
- active agent
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 abstract 2
- 229960004574 azelastine Drugs 0.000 abstract 2
- 229950005627 embonate Drugs 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3738641 | 1987-11-13 | ||
| DE3738641 | 1987-11-13 | ||
| SG153894 | 1994-10-21 | ||
| SG153894A SG153894G (en) | 1987-11-13 | 1994-10-21 | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK630088D0 DK630088D0 (da) | 1988-11-11 |
| DK630088A true DK630088A (da) | 1989-05-14 |
| DK170339B1 DK170339B1 (da) | 1995-08-07 |
Family
ID=25861795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK630088A DK170339B1 (da) | 1987-11-13 | 1988-11-11 | Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0316639B1 (da) |
| JP (1) | JP2730581B2 (da) |
| AT (1) | ATE106883T1 (da) |
| CA (1) | CA1317595C (da) |
| DE (1) | DE3850044D1 (da) |
| DK (1) | DK170339B1 (da) |
| ES (1) | ES2053679T3 (da) |
| HK (1) | HK135494A (da) |
| SG (1) | SG153894G (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59006184D1 (de) * | 1989-05-05 | 1994-07-28 | Asta Medica Ag | Salze des Azelastins mit verbesserter Löslichkeit. |
| JPH04198180A (ja) * | 1990-11-28 | 1992-07-17 | Eezai Kagaku Kk | ベンジルフタラゾン誘導体の製造方法 |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| PL2486942T3 (pl) | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH572914A5 (da) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab |
-
1988
- 1988-10-28 ES ES88117969T patent/ES2053679T3/es not_active Expired - Lifetime
- 1988-10-28 EP EP88117969A patent/EP0316639B1/de not_active Expired - Lifetime
- 1988-10-28 AT AT88117969T patent/ATE106883T1/de not_active IP Right Cessation
- 1988-10-28 DE DE3850044T patent/DE3850044D1/de not_active Expired - Lifetime
- 1988-11-10 CA CA000582812A patent/CA1317595C/en not_active Expired - Lifetime
- 1988-11-11 DK DK630088A patent/DK170339B1/da not_active IP Right Cessation
- 1988-11-14 JP JP63285946A patent/JP2730581B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-21 SG SG153894A patent/SG153894G/en unknown
- 1994-12-01 HK HK135494A patent/HK135494A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0316639A3 (en) | 1990-07-18 |
| DE3850044D1 (de) | 1994-07-14 |
| SG153894G (en) | 1995-03-17 |
| JP2730581B2 (ja) | 1998-03-25 |
| JPH01153686A (ja) | 1989-06-15 |
| DK170339B1 (da) | 1995-08-07 |
| CA1317595C (en) | 1993-05-11 |
| ATE106883T1 (de) | 1994-06-15 |
| EP0316639A2 (de) | 1989-05-24 |
| HK135494A (en) | 1994-12-09 |
| DK630088D0 (da) | 1988-11-11 |
| EP0316639B1 (de) | 1994-06-08 |
| ES2053679T3 (es) | 1994-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0548114T5 (da) | Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
| ATE216590T1 (de) | Arzneimittelformulierungen für il-12 | |
| DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK254787D0 (da) | Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel | |
| DK605786D0 (da) | Stabiliserede human-vaevsplasminogenaktivator-praeparater | |
| IL109901A0 (en) | Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them | |
| NO921382D0 (no) | Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene | |
| NO933524L (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
| ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
| DK127588A (da) | Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| DK122191A (da) | Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
| DK630088D0 (da) | Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel | |
| NO883047L (no) | Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytiske tilberedninger inneholdende dem ogderes anvendelse. | |
| FI884545A0 (fi) | Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar. | |
| DK88087D0 (da) | Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem | |
| DK524489A (da) | Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer | |
| DK4287D0 (da) | Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler | |
| DK34888D0 (da) | Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer | |
| NO882030D0 (no) | Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel. | |
| IT8721055A0 (it) | Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono. | |
| AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
| SE8503513D0 (sv) | Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PUP | Patent expired |